If you're on Medicaid and asking "does Medicaid cover Ozempic?" — the honest answer is: it depends, and it depends a lot on where you live and what diagnosis is driving the request.
The short version: most Medicaid programs cover semaglutide for type 2 diabetes. Coverage for GLP-1 drugs as weight loss medication is much more fragmented, and in many states, it's simply not available unless you have a qualifying comorbidity. But the landscape is changing, and there are paths to coverage that many patients and even some providers don't know about.
This guide breaks down how Medicaid GLP-1 coverage actually works, which states are more generous, what prior authorization requires, and what to do when coverage is denied.
How Medicaid GLP-1 Coverage Works — The Basics
Medicaid is administered at the state level, which means each state can set its own formulary (list of covered drugs) and its own prior authorization requirements. This creates enormous variation in coverage from state to state — even within the same year.
For GLP-1 agonists, coverage generally falls into three tiers:
Tier 1 — Covered for diabetes (most states): Ozempic (semaglutide 0.5mg/1mg/2mg) is FDA-approved to improve glycemic control in adults with type 2 diabetes. This is the indication most Medicaid programs cover. The same logic applies to Victoza (liraglutide) and Trulicity (dulaglutide). If you have a type 2 diabetes diagnosis, your chances of Medicaid coverage are reasonably good.
Tier 2 — Covered for obesity with conditions (some states): Wegovy (semaglutide 2.4mg) and Zepbound (tirzepatide) are FDA-approved for chronic weight management. Some state Medicaid programs cover these, but typically require a BMI of 30 or higher (or 27+ with a qualifying comorbidity like hypertension, sleep apnea, or PCOS) plus prior authorization.
Tier 3 — Excluded from coverage (many states): Several state Medicaid programs explicitly exclude anti-obesity medications from coverage, categorizing them as "lifestyle drugs." This classification has been legally challenged, but many exclusions remain in place.
State-by-State GLP-1 Medicaid Coverage Overview
Coverage changes frequently — verify with your state Medicaid office for current status. The information below reflects publicly available formulary data as of early 2026.
States with Relatively Broad Coverage
| State | Covers for Diabetes | Covers for Obesity |
|---|---|---|
| California | Yes | Yes (with PA) |
| New York | Yes | Yes (with PA) |
| Colorado | Yes | Yes (with PA) |
| Oregon | Yes | Yes (with PA) |
| Washington | Yes | Yes (with PA + criteria) |
| Massachusetts | Yes | Yes (with PA) |
| Minnesota | Yes | Yes (with PA) |
States with Diabetes-Only or Restricted Coverage
| State | Covers for Diabetes | Covers for Obesity |
|---|---|---|
| Texas | Yes (with PA) | No (excluded) |
| Florida | Yes (with PA) | Limited |
| Georgia | Yes | No |
| Tennessee | Yes | No |
| Alabama | Yes | No |
| Mississippi | Yes | No |
| Arizona | Yes | Limited (with criteria) |
How to Check Your State's Current Coverage
The most reliable sources:
- Your state Medicaid website — search "[your state] Medicaid preferred drug list" or "formulary"
- Call Medicaid member services — the number is on your Medicaid card
- Ask your prescriber's office — they often have the most current information for their patient population
- NeedyMeds.org — a nonprofit database that tracks assistance programs by state
Prior Authorization: What Medicaid Requires
Even in states where GLP-1 drugs are covered, almost all require prior authorization (PA). Understanding what this process requires helps you prepare — and helps your provider submit a stronger request.
Typical PA Requirements for GLP-1 Obesity Coverage
Clinical criteria your provider will document:
- BMI ≥ 30 kg/m² (or ≥ 27 with qualifying comorbidity)
- One or more weight-related comorbidities: hypertension, type 2 diabetes or prediabetes, dyslipidemia, obstructive sleep apnea, or cardiovascular disease
- Documentation of prior lifestyle interventions (diet, exercise counseling) that did not produce adequate weight control
- Statement that the patient is not pregnant and does not have a contraindication to GLP-1 therapy
What "prior lifestyle interventions" means: Most programs want to see at least 3–6 months of documented diet and exercise counseling, though "documented" can mean as little as a note in the medical record that the conversation occurred. Your primary care doctor likely already has this documentation if you've discussed weight at any visit.
Duration of approval: PA approvals are typically granted for 6–12 months and require renewal. Renewals typically require documentation of clinical benefit — usually defined as at least 5% weight loss from baseline.
If Your Medicaid PA Is Denied
Denial is not the end. Many first-time PA requests for GLP-1 obesity coverage are denied, but a meaningful proportion of those are reversed on appeal. Here's how to approach it:
Step 1: Request the Specific Denial Reason
Medicaid must give you a written explanation. Common reasons:
- "Diagnosis does not meet criteria" — often means the claim was coded for obesity only, not a qualifying comorbidity
- "Prior therapies not documented" — the record didn't show documented lifestyle intervention
- "Drug not on formulary" — the specific formulation (e.g., Wegovy 2.4mg) isn't covered; your provider may be able to request Ozempic at a different dose
Step 2: File an Appeal
You have a right to appeal any Medicaid coverage denial. The appeal process is usually:
- Submit written appeal within 90 days (30 days for expedited)
- Your provider submits a letter of medical necessity
- A peer-to-peer review call between your provider and the Medicaid medical director (if available)
Step 3: Request a Fair Hearing
If the internal appeal fails, you can request a state fair hearing — a formal proceeding with an independent hearing officer. Success rates in fair hearings vary but can be meaningful for patients with strong clinical documentation.
Patient Advocacy Resources
- Patient Advocate Foundation (patientadvocate.org) — offers case managers who help navigate insurance denials
- Obesity Action Coalition (obesityaction.org) — has resources specifically for GLP-1 coverage denials
- Your state's Medicaid patient advocacy office (every state has one)
If Medicaid Won't Cover GLP-1s: Other Options
If you exhaust the appeal process and still can't get Medicaid coverage, you're not out of options.
Manufacturer Patient Assistance Programs
- Novo Nordisk NovoCare — assists patients with low income who don't qualify for other coverage. Income-based eligibility.
- Eli Lilly Insulin Value Program — for Mounjaro/Zepbound, though eligibility for Medicaid patients is limited
These programs have income thresholds and sometimes exclude Medicaid enrollees, but it's worth checking if your state's Medicaid excludes obesity drugs.
Telehealth + Compounded Semaglutide
Some telehealth providers offer compounded semaglutide (typically from an FDA-registered 503B pharmacy) at $150–$400/month without insurance. This is a meaningful out-of-pocket cost, but it can be a bridge while you work through coverage issues. See our guide to getting GLP-1 medications without insurance for a full comparison of these options.
Community Health Centers
Federally Qualified Health Centers (FQHCs) operate on a sliding fee scale and sometimes have access to medication assistance programs. If you're on Medicaid, cost-sharing at FQHCs is minimal.
The Policy Landscape Is Shifting
The Inflation Reduction Act and ongoing state-level advocacy have created significant pressure to expand Medicaid coverage for anti-obesity medications. In 2025 and 2026, several states expanded their formularies after legislative action. The Treat and Reduce Obesity Act — which would mandate Medicare coverage and set a precedent for Medicaid — has been proposed in multiple congressional sessions.
This means coverage you're denied today may be available in your state within 12–18 months. Staying informed through your state Medicaid office and patient advocacy organizations matters.
Questions to Ask Your Provider Before Pursuing Medicaid Coverage
Bring these to your next appointment to make the PA process smoother:
- "Do you have documentation of our prior weight management discussions in my record?"
- "Is my chart coded with my comorbidities — hypertension, PCOS, sleep apnea — specifically?"
- "Do you have experience submitting PA requests for GLP-1s through Medicaid?"
- "If the PA is denied, can we do a peer-to-peer review?"
- "Is there a patient advocate or social worker at this practice who helps with insurance coverage?"
What to Know Before You Start
A note on our insurance coverage guide: the principles for Medicaid prior authorization are similar to those for commercial insurance — documented clinical need, evidence-based criteria, and a prescriber who can articulate medical necessity clearly. The main difference with Medicaid is that state policies vary more dramatically and the appeals process has formal legal protections.
GLP-1 coverage through Medicaid is genuinely difficult in many states — but patients who work with informed providers and understand the appeals process have meaningful success in getting coverage reversed. Don't accept an initial denial as the final word.
Frequently Asked Questions
Does Medicaid cover Ozempic for weight loss? It depends on your state and diagnosis. Most Medicaid programs cover Ozempic for type 2 diabetes. Coverage for weight loss (using the Wegovy formulation) is more limited and varies by state. Fewer than half of states explicitly cover anti-obesity medications through Medicaid as of 2026. Prior authorization is almost always required, and your BMI and comorbidities will be factors in approval.
Which states cover GLP-1 drugs for obesity through Medicaid? States with relatively broad GLP-1 obesity coverage include California, New York, Colorado, Oregon, Washington, Massachusetts, and Minnesota. States with diabetes-only or excluded coverage include Texas, Florida, Georgia, Tennessee, Alabama, and Mississippi. Coverage policies change frequently — always verify with your state Medicaid office for current status.
How do I get Medicaid to cover Ozempic or Wegovy? Work with your provider to submit a prior authorization that documents your BMI, qualifying comorbidities (hypertension, sleep apnea, PCOS, etc.), and prior lifestyle interventions. If denied, you have the right to appeal, and many initial denials are reversed when stronger medical necessity documentation is submitted. Consider requesting a peer-to-peer review between your provider and the Medicaid medical director.
Does Medicaid cover compounded semaglutide? No. Medicaid does not cover compounded medications. Compounded semaglutide from specialty pharmacies is not reimbursable through Medicaid and would be an out-of-pocket cost, typically $150–$400 per month.